These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effects of compound X, a novel potent inhibitor of acyl-coenzyme A:cholesterol O-acyltransferase, on the adrenal gland of rats. Nishimura J; Ohmichi K; Wato E; Saito T; Takashima K; Tanaka T; Hiwatashi Y; Kobayashi K; Tsujimoto T; Asahiyama M; Itagaki K; Tanabe S; Kato N; Amano Y Exp Toxicol Pathol; 2013 Nov; 65(7-8):961-71. PubMed ID: 23462190 [TBL] [Abstract][Full Text] [Related]
10. Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR145237. Matsuo M; Hashimoto M; Suzuki J; Iwanami K; Tomoi M; Shimomura K Toxicol Appl Pharmacol; 1996 Oct; 140(2):387-92. PubMed ID: 8887456 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor. Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714 [TBL] [Abstract][Full Text] [Related]
12. [Hypolipidemic action of F-1394, an acyl-CoA: cholesterol acyltransferase (ACAT) inhibitor, in high-fat diet fed beagle dogs]. Kusunoki J; Aragane K; Kitamine T; Yamaura T; Ohnishi H Yakugaku Zasshi; 1997 Apr; 117(4):233-41. PubMed ID: 9167444 [TBL] [Abstract][Full Text] [Related]
13. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity. Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599 [TBL] [Abstract][Full Text] [Related]
14. Biochemical alterations in guinea pig adrenal cortex following administration of PD 132301-2, an inhibitor of acyl-CoA:cholesterol acyltransferase. Wolfgang GH; MacDonald JR; Vernetti LA; Pegg DG; Robertson DG Life Sci; 1995 Feb; 56(13):1089-93. PubMed ID: 9001442 [TBL] [Abstract][Full Text] [Related]
15. ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs. LaPensee CR; Mann JE; Rainey WE; Crudo V; Hunt SW; Hammer GD Endocrinology; 2016 May; 157(5):1775-88. PubMed ID: 26986192 [TBL] [Abstract][Full Text] [Related]
16. Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture. Junquero D; Pilon A; Carilla-Durand E; Patoiseau JF; Tarayre JP; Torpier G; Staels B; Fruchart JC; Colpaert FC; Clavey V; Delhon A Biochem Pharmacol; 2001 Feb; 61(4):387-98. PubMed ID: 11226372 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster. Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666 [TBL] [Abstract][Full Text] [Related]
18. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters. Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits. Matsui Y; Horiuchi K; Yamamoto K; Kanai K Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647 [TBL] [Abstract][Full Text] [Related]